Skip to content

CNBSAmplify Seymour Cannabis ETF

Grow my money6y track recordRanked #1,770 of 2,960 in this goal

Seeks to provide investors capital appreciation.

By Amplify ETFs · Launched 2019

Annual Cost

0.76%

#3,883 of 5,562 · expensive

Fund Size

$87M

#3,074 of 5,562 · mid-size

Return (1Y)Goal

+99.3%

Track Record

6 years

#1,936 of 5,562 · seasoned

Performance

Total-return NAV · USD
Growth of $10,000
$19,544+95.4%

Total-return NAV, USD. Net of fund fees, before tax.

Classification

How Beacon categorizes this fund

Asset class

Equity

Strategy

Active selection

Focus

Cannabis

What it actually holds

By weight

Concentration

Top 10 holdings = 106.6% of fundconcentrated

TREASURY BILL
40.5%
TREASURY BILL
21.9%
TREASURY BILL
13.5%
Curaleaf Holdings Inc
11.4%
TREASURY BILL
10.5%
Innovative Industrial Properti
2.3%
Invesco Government & Agency Po
2.0%
TREASURY BILL
1.8%
WM Technology Inc
1.5%
TREASURY BILL
1.1%

Asset allocation

Stocks
90.0%
Other
12.4%

By sector

Healthcare
63.1%
Real Estate
13.8%
Technology
10.7%
Consumer Defensive
7.0%
Consumer Cyclical
3.4%
Financial Services
1.9%
Industrials
0.1%

Risk profile

Last 12 months · Sharpe & Sortino need 3+ years
Volatility (1Y)
105.8%High

Year-on-year price swings

Max drawdown
-95.7%Severe

Worst peak-to-trough loss

Sharpe (3Y)
0.29Below average
Sortino (3Y)
0.48Moderate downside risk

Where to buy

Listing

Exchange
NYSE Arca

Full fund details

Objective
Seeks to provide investors capital appreciation.
Strategy
Invests primarily in U.S. companies engaged in cannabis and hemp-related activities. Actively managed, focusing on firms deriving 50% or more of revenue from the cannabis ecosystem across various classifications.
Inception date
July 15, 2019
Fund family
Amplify ETFs

What's next?

You've reviewed CNBS. Save it to your watchlist to track it alongside the other funds you're weighing.

Data updated on 2026-06-19